Literature DB >> 22237455

Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Linlin Zhang1, Min Jiao, Lei Li, Dapeng Wu, Kaijie Wu, Xiang Li, Guodong Zhu, Qiang Dang, Xinyang Wang, Jer-Tsong Hsieh, Dalin He.   

Abstract

PURPOSE: Prostate cancer (PCa) becomes lethal when cancer cells develop into castration-resistant PCa, which remains incurable because of the poor understanding of their cell origin and characteristics. We aim to investigate the potential role of cancer stem cells (CSCs) in PCa progression.
METHODS: Human PCa cell lines (LNCaP, 22RV1, DU145 and PC-3) were plated in serum-free suspension culture system allowed for tumorsphere forming. To evaluate the CSC characteristics of tumorspheres, the self-renewal, chemoresistance, tumorigenicity of the PCa tumorsphere cells, and the expression levels of stemness-related proteins in the PCa tumorsphere cells were assessed, comparing with the parental adherent cells.
RESULTS: Tumorsphere cells from PCa cell lines displayed enhanced self-renewal, chemoresistance and tumor-initiating capacity when compared with the adherent cells. Additionally, these cells overexpressed CSC marker CD44. Also, the tumorsphere cells expressed high levels of "stemness" genes Gli1, ABCG2 and Bmi-1.
CONCLUSIONS: Collectively, these data demonstrated that tumorspheres derived from PCa cells possess chemoresistant and CSC properties. Our study suggests that the identification of PCa CSCs could provide new insight into the lethal phenotype of PCa and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237455     DOI: 10.1007/s00432-011-1146-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  52 in total

1.  Cancer stem cells and metastasis: lethal seeds.

Authors:  Max S Wicha
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

Review 2.  Using the neurosphere assay to quantify neural stem cells in vivo.

Authors:  Gregory P Marshall; Brent A Reynolds; Eric D Laywell
Journal:  Curr Pharm Biotechnol       Date:  2007-06       Impact factor: 2.837

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

Authors:  Te Liu; Fuhui Xu; Xiling Du; Dongmei Lai; Tianjin Liu; Yarui Zhao; Qin Huang; Lizhen Jiang; Wenbin Huang; Weiwei Cheng; Zhixue Liu
Journal:  Mol Cell Biochem       Date:  2010-03-12       Impact factor: 3.396

Review 5.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

Review 6.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

7.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 8.  Cancer stem cells: cell culture, markers, and targets for new therapies.

Authors:  Candace A Gilbert; Alonzo H Ross
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

9.  Chemotherapy and cancer stem cells.

Authors:  Jeremy N Rich; Shideng Bao
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

10.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

View more
  39 in total

1.  Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Authors:  Matthias T Stephan; Sirkka B Stephan; Peter Bak; Jianzhu Chen; Darrell J Irvine
Journal:  Biomaterials       Date:  2012-05-15       Impact factor: 12.479

2.  TNF-α induced epithelial mesenchymal transition increases stemness properties in renal cell carcinoma cells.

Authors:  Linlin Zhang; Min Jiao; Kaijie Wu; Lei Li; Guodong Zhu; Xinyang Wang; Dalin He; Dapeng Wu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium.

Authors:  Naijin Xu; Xiezhao Li; Masami Watanabe; Hideo Ueki; Hao Hu; Na Li; Motoo Araki; Koichiro Wada; Abai Xu; Chunxiao Liu; Yasutomo Nasu; Peng Huang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

4.  Enrichment and characterization of cancer stem-like cells in ultra-low concentration of serum and non-adhesive culture system.

Authors:  Junfeng Zhang; Yunsheng Zhang; Lin Cheng; Chunlei Li; Lei Dai; Hui Zhang; Fenglian Yan; Hui Shi; Guanjun Dong; Zhaochen Ning; Wei Xu; Chuanping Si; Hongxin Deng; Huabao Xiong
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

5.  Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Authors:  Jian-Lin Wang; Jing-Ping Yu; Zhi-Qiang Sun; Su-Ping Sun
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

6.  Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.

Authors:  Li Wang; Huijie Guo; Liuqi Yang; Lihua Dong; Caiyu Lin; Jie Zhang; Ping Lin; Xiujie Wang
Journal:  Mol Cell Biochem       Date:  2013-03-31       Impact factor: 3.396

7.  Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.

Authors:  Matthias Saar; Hongjuan Zhao; Rosalie Nolley; Sarah R Young; Ilsa Coleman; Peter S Nelson; Robert L Vessella; Donna M Peehl
Journal:  Cancer Lett       Date:  2014-07-03       Impact factor: 8.679

Review 8.  Metformin and prostate cancer stem cells: a novel therapeutic target.

Authors:  M J Mayer; L H Klotz; V Venkateswaran
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-28       Impact factor: 5.554

Review 9.  Searching for prostate cancer stem cells: markers and methods.

Authors:  Benjamin Sharpe; Mark Beresford; Rebecca Bowen; John Mitchard; Andrew D Chalmers
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

10.  Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.

Authors:  Dong-Rong Yang; Xian-Fan Ding; Jie Luo; Yu-Xi Shan; Ronghao Wang; Shin-Jen Lin; Gonghui Li; Chiung-Kuei Huang; Jin Zhu; Yuhchyau Chen; Soo Ok Lee; Chawnshang Chang
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.